This inventor holds 1 USPTO granted patent. Top assignee: Insitro, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Benson Chen in DNA-Encoded Libraries
Introduction
Benson Chen is an accomplished inventor based in Palo Alto, CA. He has made significant contributions to the field of molecular modeling, particularly in the area of DNA-encoded libraries. His innovative work has led to the development of advanced methodologies that enhance the predictive capabilities of machine learning models in drug discovery.
Latest Patents
Benson Chen holds a patent for "Synthon embeddings for modeling DNA-encoded libraries." This patent involves modeling DEL data using factorized molecular representations, such as hierarchical mono-synthon and di-synthon building blocks. These representations leverage the inherent hierarchical structure of molecules, allowing for improved predictions in compound-target binding affinity. The machine learning models trained with these representations achieve higher enrichment scores, which correlate well with actual binding affinities.
Career Highlights
Benson is currently employed at Insitro, Inc., where he continues to push the boundaries of innovation in the biotech industry. His work focuses on integrating machine learning with molecular biology to streamline the drug discovery process. With a patent portfolio that includes 1 patent, he is recognized for his contributions to enhancing the efficiency of molecular modeling.
Collaborations
Benson collaborates with talented individuals such as Mohammad Muneeb Sultan and Theofanis Karaletsos. Together, they work on advancing the methodologies that underpin modern drug discovery techniques.
Conclusion
Benson Chen's innovative work in modeling DNA-encoded libraries exemplifies the intersection of technology and biology. His contributions are paving the way for more effective drug discovery processes, showcasing the potential of machine learning in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile